Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Questions and Answers

Questions and Answers Questions and Answers reasonable this without most in Nodosa possibilities patient Polyarteritis Therapy other of disease would be physical signs fatty or metastatic carcinoma of the liver is the metamorphosis What treatment choice of for polyar¬ or and obstructive The teritis nodosa? incomplete early jaundice. serum determinations be most to Illinois enzyme likely MD, alkaline oxaloa- are helpful phosphatase, glutamic cetic transaminase trans- In the (GOT), glutamic pyruvic of management general polyarteritis, In aminase and lactic dehydrogenase measures (GPT), (LD). transfusions, analgesics, including alkaline the GOT and and phos¬ treatment for or fatty metamorphosis heart failure hypertension would be or values normal ele¬ be phatase slightly should may helpful. offending antigens Possibly vated and the and LD normal. In GPT Laennec's be and eliminated. sought Although subsequent cirrhosis the GOT be or have may slightly moderately the enthusiasm experiences dampened early elevated 250 the alkaline to which followed the (40 units), phospha¬ initial of the alleviation reports below and the GPT and tase of with Bodansky units, adrenocortical no bet¬ polyarteritis steroids, LD values normal or elevated. In meta¬ ter treatment is available. doses slightly are often Large or static carcinoma involvement of and side reactions be and lymphomatous http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Questions and Answers

JAMA , Volume 184 (8) – May 25, 1963

Loading next page...
 
/lp/american-medical-association/questions-and-answers-fQVLJOcR3o
Publisher
American Medical Association
Copyright
Copyright © 1963 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1963.03700210101030
Publisher site
See Article on Publisher Site

Abstract

Questions and Answers reasonable this without most in Nodosa possibilities patient Polyarteritis Therapy other of disease would be physical signs fatty or metastatic carcinoma of the liver is the metamorphosis What treatment choice of for polyar¬ or and obstructive The teritis nodosa? incomplete early jaundice. serum determinations be most to Illinois enzyme likely MD, alkaline oxaloa- are helpful phosphatase, glutamic cetic transaminase trans- In the (GOT), glutamic pyruvic of management general polyarteritis, In aminase and lactic dehydrogenase measures (GPT), (LD). transfusions, analgesics, including alkaline the GOT and and phos¬ treatment for or fatty metamorphosis heart failure hypertension would be or values normal ele¬ be phatase slightly should may helpful. offending antigens Possibly vated and the and LD normal. In GPT Laennec's be and eliminated. sought Although subsequent cirrhosis the GOT be or have may slightly moderately the enthusiasm experiences dampened early elevated 250 the alkaline to which followed the (40 units), phospha¬ initial of the alleviation reports below and the GPT and tase of with Bodansky units, adrenocortical no bet¬ polyarteritis steroids, LD values normal or elevated. In meta¬ ter treatment is available. doses slightly are often Large or static carcinoma involvement of and side reactions be and lymphomatous

Journal

JAMAAmerican Medical Association

Published: May 25, 1963

There are no references for this article.